These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6388363)

  • 1. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 4. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
    Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
    J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
    Engelhardt DM; Rudorfer L; Rosen B
    J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential prediction of response to thiothixene and placebo in borderline and schizotypal personality disorders.
    Goldberg SC; Schulz SC; Resnick RJ; Hamer RM; Schulz PM
    Psychopharmacol Bull; 1987; 23(3):342-6. PubMed ID: 3324147
    [No Abstract]   [Full Text] [Related]  

  • 13. An open, noncomparative study of amoxapine in borderline disorders.
    Jensen HV; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.
    Schulz SC
    Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650
    [No Abstract]   [Full Text] [Related]  

  • 15. Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.
    Soloff PH; George A; Nathan S; Schulz PM; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1986; 22(1):177-82. PubMed ID: 3523575
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
    Kelwala S; Ban TA; Berney SA; Wilson WH
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 19. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
    Garbutt JC; Loosen PT
    Psychoneuroendocrinology; 1984; 9(3):311-4. PubMed ID: 6436858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of borderline patients to loxapine and chlorpromazine.
    Leone NF
    J Clin Psychiatry; 1982 Apr; 43(4):148-50. PubMed ID: 7040351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.